SEC Filings

Filing date	Description	Form	Filing Group	Issuer	View
Feb 20, 2020	Statement of changes in beneficial ownership of securities	4	3,4,5	Arcturus Therapeutics Holdings Inc.	0000899243-20-005383.pdf 0000899243-20-005383.rtf View HTML
Feb 20, 2020	Statement of changes in beneficial ownership of securities	4	3,4,5	Arcturus Therapeutics Holdings Inc.	0000899243-20-005386.pdf 0000899243-20-005386.rtf View HTML
Feb 20, 2020	Statement of changes in beneficial ownership of securities	4	3,4,5	Arcturus Therapeutics Holdings Inc.	0000899243-20-005387.pdf 0000899243-20-005387.rtf View HTML
Feb 20, 2020	Statement of changes in beneficial ownership of securities	4	3,4,5	Arcturus Therapeutics Holdings Inc.	0000899243-20-005389.pdf 0000899243-20-005389.rtf View HTML
Jan 10, 2020	Report of unscheduled material events or corporate event	8-K	Current Reports	Arcturus Therapeutics Holdings Inc.	0001193805-20-000030.pdf 0001193805-20-000030.rtf 0001193805-20-000030.xls View HTML
Dec 16, 2019	UPLOAD	UPLOAD	Other	Arcturus Therapeutics Holdings Inc.	0000000000-19-016451.pdf 0000000000-19-016451.rtf View HTML
Dec 12, 2019	Simplified registration form	S-3	Registration Statements	Arcturus Therapeutics Holdings Inc.	0001193125-19-312823.pdf 0001193125-19-312823.rtf 0001193125-19-312823.xls View HTML
Dec 09, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Arcturus Therapeutics Holdings Inc.	0000899243-19-028803.pdf 0000899243-19-028803.rtf View HTML
Dec 05, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Arcturus Therapeutics Holdings Inc.	0000899243-19-028631.pdf 0000899243-19-028631.rtf View HTML
Nov 08, 2019	Quarterly report which provides a continuing view of a company's financial position	10-Q	Quarterly Filings	Arcturus Therapeutics Holdings Inc.	0001564590-19-042017.pdf 0001564590-19-042017.rtf 0001564590-19-042017.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Data provided by Kaleidoscope.